Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-15 to 2023-10-14
Current total value of award: $2897172
Description: NO COST EXTENSION TO THE AWARD OF CYTOSORBENTS' DHA STTR PHASE III MEDICAL R&D CONTRACT FOR "DEVELOPMENT OF A HIGHLY EFFICIENT ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM BLOOD AND PLASMA FOR TRANSFUSION"